Palisade Bio_Logos(4.22)VSM.png
Palisade Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022 08:45 ET | Palisade Bio, Inc.
Carlsbad, CA, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc., (Nasdaq: PALI) a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI)...